BlackRock Inc. - EVELO BIOSCIENCES INC ownership

EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 50 filers reported holding EVELO BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of EVELO BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$208,780
-89.5%
1,155,394
-6.3%
0.00%
Q4 2022$1,984,617
-21.2%
1,232,681
+2.3%
0.00%
Q3 2022$2,519,000
+31.1%
1,205,366
+32.3%
0.00%
Q2 2022$1,922,000
-72.5%
910,953
-55.9%
0.00%
Q1 2022$6,999,000
-45.3%
2,064,198
-2.0%
0.00%
Q4 2021$12,792,000
-1.3%
2,107,338
+14.5%
0.00%
Q3 2021$12,954,000
-48.9%
1,840,250
-0.2%
0.00%
-100.0%
Q2 2021$25,330,000
+45.3%
1,843,502
+13.1%
0.00%0.0%
Q1 2021$17,438,000
+10.9%
1,629,734
+25.3%
0.00%0.0%
Q4 2020$15,720,000
+217.8%
1,300,252
+38.5%
0.00%
Q3 2020$4,946,000
+22.9%
938,625
+14.3%
0.00%
Q2 2020$4,023,000
+38.6%
821,011
+6.2%
0.00%
Q1 2020$2,903,000
-5.2%
773,135
+2.5%
0.00%
Q4 2019$3,061,000
-33.3%
754,051
+0.2%
0.00%
Q3 2019$4,588,000
-22.0%
752,179
+14.9%
0.00%
Q2 2019$5,879,000
+13.7%
654,753
+1.3%
0.00%
Q1 2019$5,169,000
-40.8%
646,233
-3.7%
0.00%
Q4 2018$8,729,000
+175.1%
670,944
+157.5%
0.00%
Q3 2018$3,173,000
+2.7%
260,537
-0.5%
0.00%
Q2 2018$3,090,000261,7410.00%
Other shareholders
EVELO BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 3,063,505$37,038,00014.47%
Mayo Clinic 484,953$5,863,0007.05%
Flagship Pioneering Inc. 22,900,069$276,862,0005.04%
Trustees of Columbia University in the City of New York 113,850$1,376,0001.84%
Alphabet Inc. 1,060,495$12,821,0000.62%
Artal Group S.A. 700,000$8,463,0000.18%
Larson Financial Group LLC 28,353$343,0000.12%
PEDDOCK CAPITAL ADVISORS, LLC 3,663$44,0000.02%
CREDIT SUISSE AG/ 2,705,511$32,710,0000.02%
FMR LLC 6,803,365$82,253,0000.01%
View complete list of EVELO BIOSCIENCES INC shareholders